Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 78 #1
TickerBV [NASD]
CompanyBazaarvoice, Inc.
IndustryApplication Software
Market Cap504.08MEPS (ttm)-0.52
P/E-EPS this Y-1.40%
Forward P/E-EPS next Y48.30%
PEG-EPS past 5Y-50.70%
P/S2.80EPS next 5Y15.00%
P/B2.58EPS Q/Q31.60%
Dividend-Sales Q/Q15.10%
Insider Own1.30%Inst Own81.40%
Insider Trans-0.23%Inst Trans-0.27%
Short Float8.28%EarningsMar 03/a
Analyst Recom2.10Target Price10.57
Avg Volume369.26K52W Range5.85 - 9.39
Mar-04-15 04:24PMBAZAARVOICE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Mar-04-15 04:07PMAnalyst: Bazaarvoice Is 'Not As Bad As It Looks' Benzinga
Mar-04-15 10:31AMBazaarvoice (BV) Stock Is Down Today After Earnings Report at TheStreet
Mar-03-15 07:23PMBazaarvoice Plunges 14%: FY16 Growth Well Below Consensus on Product 'Transitions' at
Mar-03-15 06:05PMBazaarvoice narrows Q3 losses, boosts revenue year-over-year at
Mar-03-15 05:13PMBazaarvoice reports 3Q loss AP
Mar-03-15 04:13PM4:13 pm Bazaarvoice beats by $0.06, reports revs in-line
Mar-03-15 04:12PMBAZAARVOICE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Mar-03-15 04:05PMBazaarvoice, Inc. Announces its Financial Results for the Third Fiscal Quarter of 2015 GlobeNewswire
Mar-03-15 07:07AMQ3 2015 Bazaarvoice Inc Earnings Release - After Market Close CCBN
Bazaarvoice, Inc. provides various social commerce solutions. The company offers its solutions through Bazaarvoice conversations platform, a software as a service platform that enable clients to capture, display, and analyze online word of mouth, including ratings and reviews, questions and answers, stories, photos, videos, long-format narratives, and other forms of consumer-generated content. It also provides Bazaarvoice connections solutions, such as BrandAnswers that allows brands to interact directly with consumers on retail Websites within the network to answer questions and provide suggestions on alternative products; and Review Response, which enables brands to interact with consumers by responding to reviews posted on retail Websites. In addition, the company offers Bazaarvoice analytics solutions, including Intelligence solution that allows clients to derive market, consumer, and product insights from the underlying data collected on their behalf of Bazaarvoice conversations platform; and Workbench Analytics solution, which allows to generate reports highlighting simple ratings trends, text analysis, and product and service issue identification, as well as perform self-service administration. Further, it provides Bazaarvoice Curations, which enables brands to collect, curate, and display consumer-generated images, video, and social content on their Websites; Bazaarvoice media solution that sells advertising on behalf of retailers, brands, and agencies; and provides capabilities that incorporate consumers' authentic opinions in advertising campaigns. The company serves retail, consumer products, travel and leisure, technology, telecommunications, financial services, healthcare, and automotive industries. It offers its solutions through a direct sales team primarily in the United States, the United Kingdom, Australia, France, Germany, Sweden, the Netherlands, and Singapore. Bazaarvoice, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cannon MarcExecutive VP, Client ServicesJan 08Sale8.342,39519,98046,535Jan 12 11:41 AM
MEREDITH THOMAS JDirectorJun 11Buy7.2710,00072,66147,438Jun 11 03:04 PM
Offerdahl JamesChief Financial OfficerJun 09Buy7.1710,00071,67891,921Jun 09 12:02 PM
Hurt Brett A.DirectorJun 09Sale7.4911,90189,1943,522,305Jun 10 03:30 PM
Hurt Brett A.DirectorJun 09Sale7.463,93129,342346,122Jun 10 03:30 PM
CompanyCyclacel Pharmaceuticals, Inc.
Market Cap25.30MEPS (ttm)-0.88
P/E-EPS this Y26.30%
Forward P/E-EPS next Y4.20%
PEG-EPS past 5Y38.20%
P/S14.06EPS next 5Y-
P/B1.02EPS Q/Q31.30%
Dividend-Sales Q/Q133.30%
Insider Own7.47%Inst Own7.90%
Insider Trans0.18%Inst Trans-4.47%
Short Float3.79%EarningsMar 24/a
Analyst Recom3.00Target Price9.00
Avg Volume1.01M52W Range0.51 - 4.14
Mar-04-15 06:00AMCyclacel Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire
Mar-03-15 05:33PMCyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
Mar-02-15 08:35AMClinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels PR Newswire
Feb-06-15 04:22PMCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule EDGAR Online
Feb-03-15 07:00AMCyclacel Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference GlobeNewswire
Jan-06-15 07:00AMCyclacel Pharmaceuticals to Present at the Biotech Showcase(TM) 2015 Conference GlobeNewswire
Dec-16-14 08:17AMCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Dec-16-14 07:00AMCyclacel Announces Enrollment of 486 Patients, DSMB Recommendations and That the Seamless Phase 3 Trial of Sapacitabine in AML Will Continue to Final Analysis GlobeNewswire
Dec-04-14 04:28PMCYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online
Nov-21-14 01:04PMCYCLACEL PHARMACEUTICALS, INC. Financials EDGAR Online Financials
Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. The company's oncology development programs include sapacitabine, an orally-available nucleoside analogue that interferes with DNA synthesis and repair by causing single-strand DNA breaks that could induce arrest of the cell division cycle at the G2/M checkpoint; and seliciclib, an orally-available 2nd generation CDK inhibitor that selectively inhibits a spectrum of enzyme targets comprising CDK2/E, CDK2/A, CDK7, and CDK9 that are central to the process of cell division and cell cycle control. Its other oncology development programs comprise CYC065, an orally-available 2nd generation CDK-2, -5, -9 inhibitor that helps in cancer cell growth, metastatic spread, and DNA damage repair; CYC140, an orally-available small molecule inhibitor of polo-like kinase 1; and Sapacitabine + Seliciclib, which is in Phase I trials for the treatment of cancer. The company's non-oncology programs comprise cell cycle inhibitors for the treatment of autoimmune and inflammatory diseases. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARKER SAM LDirectorNov 20Buy3.003,1009,3003,100Nov 20 04:24 PM
CompanyBob Evans Farms, Inc.
Market Cap1.09BEPS (ttm)0.84
P/E55.19EPS this Y-60.50%
Forward P/E19.41EPS next Y23.09%
PEG5.52EPS past 5Y54.60%
P/S0.83EPS next 5Y10.00%
P/B2.91EPS Q/Q8.70%
Dividend2.67%Sales Q/Q0.20%
Insider Own3.00%Inst Own87.20%
Insider Trans1.11%Inst Trans-2.97%
Short Float10.29%EarningsMar 03/a
Analyst Recom2.50Target Price53.60
Avg Volume314.27K52W Range41.74 - 60.15
Mar-04-15Downgrade Miller Tabak Buy → Hold $63 → $53
Mar-04-15Downgrade Janney Buy → Neutral
Mar-04-15Reiterated Oppenheimer Outperform $62 → $57
Mar-04-15 07:29PMLightning Round: It doesn't breakup, it goes up at CNBC
Mar-04-15 06:00PMCramer's calling the worst stock of 2015 CNBC
Mar-04-15 04:30PMUS STOCKS-Wall Street end down for 2nd day after rally; healthcare gains Reuters
Mar-04-15 02:30PMBob Evans cost-savings plan looks to cut personnel expenses at
Mar-04-15 02:20PMBOB EVANS FARMS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Mar-04-15 02:00PMBob Evans (BOBE) to Retain BEF Foods, Shares Tumble 20% - Analyst Blog Zacks
Mar-04-15 12:30PM3 Stocks, 3 trades: SWHC, AEO, BOBE CNBC
Mar-04-15 11:30AMMcDonalds menu makeover, Wayfair wows Wall St. & Bob Evans board stumbles Yahoo Finance
Mar-04-15 10:34AMStocks Open Lower In Soft Trade; Bob Evans, Alcoa Hit The Skids at Investor's Business Daily
Mar-04-15 10:22AMMiller Tabak Downgrades Bob Evans Farms, Says New CEO Might Revive Spinoff Benzinga
Bob Evans Farms, Inc. operates as a full-service restaurant company in the United States. The company conducts its operations through Bob Evans Restaurants and BEF Foods segments. As of April 25, 2014, it owned and operated 561 Bob Evans Restaurants and licensed 2 Bob Evans Express locations. The company's restaurants offers breakfast, lunch, and dinner items in family-friendly settings. It also produces and distributes fresh, smoked, and fully cooked pork sausage, ham, and hickory-smoked bacon products; ready-to-eat products, such as sandwiches, soups, and gravies; home-style refrigerated side dishes; and frozen food items primarily under the Bob Evans, Owens, and Country Creek brands. In addition, the company manufactures and sells products to foodservice accounts, including Bob Evans Restaurants, and other restaurants and food sellers. Bob Evans Farms, Inc. was founded in 1948 and is headquartered in New Albany, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOOD MARK ECFOSep 08Buy44.433,500155,5193,500Sep 09 11:20 AM
Weinstein Michael FederDirectorSep 05Buy43.942,00087,8884,323Sep 08 01:37 PM
ELSON CHARLES MDirectorSep 04Buy43.502,300100,0504,623Sep 05 12:15 PM
LUCAS G ROBERTDirectorAug 29Sale43.565,070220,85613,838Sep 03 03:58 PM
Ashworth Thomas AlanVP,CORP DEVELOPMENT & FINANCEAug 29Sale43.431,60069,4917,357Sep 03 03:57 PM
CompanyVeeva Systems Inc.
IndustryHealthcare Information Services
Market Cap3.36BEPS (ttm)0.24
P/E107.17EPS this Y36.40%
Forward P/E62.43EPS next Y20.47%
PEG3.38EPS past 5Y0.00%
P/S11.62EPS next 5Y31.67%
P/B8.72EPS Q/Q250.00%
Dividend-Sales Q/Q52.40%
Insider Own29.30%Inst Own99.10%
Insider Trans-17.95%Inst Trans1.48%
Short Float12.32%EarningsMar 03/a
Analyst Recom1.70Target Price35.50
Avg Volume929.23K52W Range17.11 - 39.81
Mar-04-15Downgrade Deutsche Bank Buy → Hold $37 → $30
Mar-04-15 05:09PMMarket Down For Second Day; H&R Block Reports Loss at Investor's Business Daily
Mar-04-15 04:19PMStocks Down For Second Day; Veeva, Middleby Slide at Investor's Business Daily
Mar-04-15 02:59PMStocks Down In Afternoon; Veeva Systems Plunges 21% at Investor's Business Daily
Mar-04-15 01:29PMStocks Pare Losses In Afternoon; Abercrombie Plunges at Investor's Business Daily
Mar-04-15 01:06PM4 Big Tech Stocks on Traders' Radars: Microsoft and More at TheStreet
Mar-04-15 10:30AMVeeva Beats Q4 Earnings, Share Price Down on Buyout Talks - Analyst Blog Zacks
Mar-04-15 09:10AMStock Futures Point Lower; Ambarella, Smith & Wesson Spike at Investor's Business Daily
Mar-03-15 06:04PMVeeva's Q4 Beat, Buyout Fail To Impress Market at Investor's Business Daily
Mar-03-15 05:03PMVeeva Drops 10% Despite FYQ4 Beat; Says Will Buy Assets for Undisclosed Terms at
Mar-03-15 04:59PMStock Market Takes A Break; Smith & Wesson Up After Close at Investor's Business Daily
Veeva Systems Inc. provides industry-specific cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. The company's solutions enable pharmaceutical and other life sciences companies to realize the benefits of cloud-based architectures and mobile applications for various business functions. Its industry cloud solutions include Veeva CRM for customer relationship management that enables physician-facing employees, such as pharmaceutical sales representatives, key account managers, and scientific liaisons to manage, track, and optimize interactions with healthcare providers in various communication channels utilizing a single integrated solution; and Veeva Vault, a cloud-based content management and collaboration solution for its customers to manage content-centric processes in various departments within a life sciences company, including clinical trials, quality management, manufacturing, sales, and marketing. The company's industry cloud solutions also comprise Veeva Network, a cloud-based customer master solution to help life sciences companies in creating and maintaining a record of the healthcare professionals and healthcare organizations with which they interact. In addition, it offers professional and support services in the areas of implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Faddis JonathanVP, General Counsel, SecretaryMar 03Sale30.8950015,4450Mar 04 04:51 PM
Sohn Young A10% OwnerFeb 25Sale30.3525,000758,8030Feb 26 04:30 PM
Sohn Young A10% OwnerFeb 25Sale30.362,50075,9010Feb 26 04:30 PM
Sohn Young A10% OwnerFeb 24Sale29.9225,000747,9130Feb 26 04:30 PM
Sohn Young A10% OwnerFeb 24Sale29.912,50074,7850Feb 26 04:30 PM
TickerCDI [NYSE]
CompanyCDI Corp.
IndustryStaffing & Outsourcing Services
Market Cap288.02MEPS (ttm)0.72
P/E20.39EPS this Y-33.00%
Forward P/E15.96EPS next Y10.84%
PEG1.13EPS past 5Y-7.70%
P/S0.25EPS next 5Y18.00%
P/B1.00EPS Q/Q17.40%
Dividend3.54%Sales Q/Q6.40%
Insider Own0.40%Inst Own57.60%
Insider Trans28.70%Inst Trans1.11%
Short Float1.17%EarningsMar 03/a
Analyst Recom3.00Target Price18.00
Avg Volume62.16K52W Range12.70 - 19.24
Mar-04-15 08:30AMCDI Corp Earnings Call scheduled for 8:30 am ET today CCBN
Mar-04-15 06:05AMCDI CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events EDGAR Online
Mar-03-15 06:48PMCDI reports 4Q loss AP
Mar-03-15 06:30PMCDI Corp. Reports Fourth Quarter and Full Year 2014 Results PR Newswire
Mar-03-15 07:07AMQ4 2014 CDI Corp Earnings Release - After Market Close CCBN
Mar-02-15 05:16PMCDI Corp. Declares First Quarter 2015 Dividend PR Newswire
Feb-03-15 05:00PMCDI Corp. To Hold Fourth Quarter 2014 and Full Year 2014 Earnings Conference Call on March 4 PR Newswire
Feb-03-15 12:09AM[$$] Credits & Debits at The Wall Street Journal
Jan-30-15 04:27PMCDI CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Jan-26-15 04:30PMCDI Corp. Names Michael S. Castleman Chief Financial Officer PR Newswire
CDI Corp., together with its subsidiaries, provides integrated engineering and technology solutions, and professional staffing services. The company operates through three segments: Global Engineering and Technology Solutions, Professional Services Staffing, and Management Recruiters International. The Global Engineering and Technology Solutions segment provides engineering and information technology solutions that include the analysis of a client's engineering or information technology needs and the development of solutions. The Professional Services Staffing segment offers skilled technical and professional personnel for discrete periods of time; and permanent placement services, as well as provides professional staffing services, such as managed services and managed staffing programs, functional staffing outsourcing, and business advisory services. The Management Recruiters International segment operates as a franchisor and provides the use of its trademarks, business systems, and training and support services to its franchisees who engage in the search and recruitment of executive, technical, professional, and managerial personnel for employment by their customers. This segment also offers training and support, implementation services, and back-office services to enable franchisees to pursue contract staffing opportunities. The company was founded in 1950 and is headquartered in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Larney Robert MExecutive Vice President & CFOMar 02Option Exercise17.066,555111,84723,967Mar 04 02:02 PM
Short Brian D.Sr. VP, CAO & General CounselFeb 25Option Exercise0.00500011,528Feb 27 02:24 PM
Larney Robert MExecutive Vice President & CFOJan 16Option Exercise10.9827,536302,34541,817Jan 20 03:55 PM
Castleman Michael SExecutive Vice PresidentNov 14Buy17.672,50044,1752,500Nov 18 10:01 AM
Larney Robert MExecutive Vice President & CFOSep 19Option Exercise0.0072014,301Sep 23 01:43 PM
CompanyLB Foster Co.
Market Cap405.72MEPS (ttm)2.61
P/E15.02EPS this Y97.90%
Forward P/E11.60EPS next Y26.03%
PEG1.31EPS past 5Y2.10%
P/S0.67EPS next 5Y11.50%
P/B1.20EPS Q/Q-7.40%
Dividend0.41%Sales Q/Q3.50%
Insider Own1.70%Inst Own81.60%
Insider Trans0.00%Inst Trans-0.81%
Short Float1.83%EarningsMar 03/b
Analyst Recom2.00Target Price55.50
Avg Volume26.55K52W Range43.77 - 57.44
Mar-04-15Downgrade Stifel Buy → Hold
Mar-04-15 02:13PML.B. Foster Q4 Earnings Beat on Inorganic Growth Success - Analyst Blog Zacks
Mar-04-15 07:18AML.B. Foster downgraded by Stifel
Mar-03-15 11:00AML.B. Foster Co Earnings Call scheduled for 11:00 am ET today CCBN
Mar-03-15 08:46AMFOSTER L B CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Mar-03-15 08:31AM8:31 am L.B. Foster beats by $0.22, beats on revs
Mar-03-15 08:28AML.B. Foster Reports Fourth Quarter Operating Results; Includes Record Annual Sales and Cash Flow GlobeNewswire
Mar-03-15 07:07AMQ4 2014 L.B. Foster Co Earnings Release - Before Market Open CCBN
Mar-02-15 05:28PMSteel Dynamics (STLD) Down to Strong Sell: Time to Dump It? - Analyst Blog Zacks
Mar-02-15 05:11PMArcelorMittal (MT) Downgraded to Strong Sell on Low Pricing - Analyst Blog Zacks
Mar-02-15 03:23PMAK Steel (AKS) Strongly Placed on Automotive Momentum - Analyst Blog Zacks
L.B. Foster Company manufactures, fabricates, and distributes products and services for the rail, construction, energy, and utility markets. It operates in three segments: Rail Products, Construction Products, and Tubular Products. The Rail Products segment provides new and used rail primarily to transit authorities, industrial companies, and rail contractors for railroad sidings, plant trackage, and other carrier and material handling applications. This segment also offers rail accessories, such as trackwork, track spikes, bolts, angle bars, and other products; designs and produces concrete railroad ties, insulated rail joints, power rails, track fasteners, coverboards, and special accessories for mass transit and other rail systems; and engineers, manufactures, and assembles friction management products, railway wayside data collection and management systems, and related products, as well as stick friction modifiers and related application systems. The Construction segment sells and rents steel sheet, H-bearing, pipe, and other piling products for foundation and earth retention requirements; manufactures and sells fabricated steel and aluminum products primarily for the highway, bridge, and transit industries, including grid reinforced concrete deck and open steel grid flooring systems, guardrails, expansion joints, bridge decking and railing, structural steel fabrications, and bridge forms and other products; and produces precast concrete buildings, such as restrooms, concession stands, and other protective storage buildings. The Tubular segment supplies pipe coatings for natural gas pipelines and utilities; and produces threaded pipe products for industrial water well and irrigation markets. The company markets its products directly in the United States, Canada, and the United Kingdom, as well as through a network of agents in Europe, South America, and Asia. L.B. Foster Company was founded in 1902 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RUSSO DAVID JSr. V.P., CFO & TreasurerJun 11Sale53.061,50079,59528,652Jun 13 09:03 AM
KASEL JOHN FSr. Vice PresidentMay 23Sale49.064,000196,24017,830May 27 03:39 PM
FOSTER LEE B IIDirectorMay 12Sale48.803,800185,44084,000May 13 05:02 PM
FOSTER LEE B IIDirectorMay 09Sale45.638,200374,16687,800May 13 05:02 PM
CompanyCentury Aluminum Co.
Market Cap1.55BEPS (ttm)1.26
P/E13.10EPS this Y-12.50%
Forward P/E5.37EPS next Y19.43%
PEG1.87EPS past 5Y53.20%
P/S0.80EPS next 5Y7.00%
P/B1.39EPS Q/Q572.70%
Dividend-Sales Q/Q25.20%
Insider Own0.40%Inst Own56.10%
Insider Trans0.00%Inst Trans3.17%
Short Float9.32%EarningsFeb 24/a
Analyst Recom2.30Target Price28.25
Avg Volume1.19M52W Range11.77 - 31.75
Mar-04-15 07:09PM10-K for Century Aluminum Co. Company Spotlight
Mar-04-15 10:55AMWhy Merrill Lynch Threw In the Towel on Aluminum at 24/7 Wall St.
Mar-04-15 10:39AMHere's a Factor Hurting Century Aluminum (CENX) Stock Today at TheStreet
Mar-03-15 01:06PMUnderstanding Century Aluminums Major Operations Market Realist
Mar-03-15 09:04AMCentury Aluminum Crashed After Its 4Q Earnings Release Market Realist
Mar-02-15 04:13PMCENTURY ALUMINUM CO Files SEC form 10-K, Annual Report EDGAR Online
Feb-26-15 02:01PMCENTURY ALUMINUM CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Feb-26-15 09:30AMCentury Aluminum Expands Share Repurchase Program Marketwired
Feb-26-15 08:47AMWeakness Seen in Century Aluminum (CENX): Stock Tanks 12.9% - Tale of the Tape Zacks
Feb-24-15 05:12PMCentury misses 4Q profit forecasts AP
Century Aluminum Company, together with its subsidiaries, produces and sells primary aluminum in the United States and Iceland. It provides standard grade and value-added primary aluminum products; and carbon products, such as anodes and cathodes. The company was founded in 1981 and is headquartered in Chicago, Illinois.
CompanyPDI, Inc.
IndustryBusiness Services
Market Cap25.04MEPS (ttm)-0.82
P/E-EPS this Y82.30%
Forward P/E-EPS next Y-9.30%
PEG-EPS past 5Y32.40%
P/S0.19EPS next 5Y15.00%
P/B0.96EPS Q/Q-107.10%
Dividend-Sales Q/Q-14.90%
Insider Own7.80%Inst Own40.80%
Insider Trans38.49%Inst Trans-13.44%
Short Float6.43%EarningsMar 03/a
Analyst Recom2.50Target Price4.00
Avg Volume54.92K52W Range1.30 - 5.44
Mar-04-15 09:50AMPDI, Inc.'s Q4 Loss Narrower Than Expected, Gives View - Analyst Blog Zacks
Mar-03-15 04:30PMPDI Inc Earnings Call scheduled for 4:30 pm ET today CCBN
Mar-03-15 04:16PMPDI INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Mar-03-15 04:05PMPDI Reports Fourth Quarter and Full Year 2014 Financial Results PR Newswire
Mar-03-15 07:07AMQ4 2014 PDI Inc Earnings Release - After Market Close CCBN
Feb-17-15 07:00AMPDI, Inc. to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on Tuesday, March 3, 2015 PR Newswire
Feb-04-15 08:35AMPDI, Inc. Subsidiary Interpace Diagnostics Announces PancraGen Benefits Reinforced in Pivotal Study Published in Endoscopy PR Newswire
Jan-16-15 05:22PMPDI INC Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online
Dec-17-14 08:58AMPDI, Inc. Subsidiary Interpace Diagnostics Announces Launch of ThyGenX Next-Generation Sequencing (NGS) Test for Cancer Risk Assessment of Thyroid Nodules PR Newswire
Nov-26-14 02:00PMInsider Trading Alert - PDII, SSI And FBIZ Traded By Insiders at TheStreet
PDI, Inc. provides outsourced commercial services to pharmaceutical, biotechnology, and healthcare companies in the United States. The company's services offer customers a range of personal and non-personal promotional options for the commercialization of their products throughout the product lifecycles, from development through maturity. It operates in three segments: Sales Services, Marketing Services, and Product Commercialization Services. The Sales Services segment focuses primarily on product detailing, which includes a sales representative meeting face-to-face with targeted physicians and other healthcare decision makers to provide a technical review of the product being promoted and deliver marketing materials, including samples. It also offers a portfolio of sales services consisting of talent acquisition services, short-term teams, and vacancy coverage services. The Marketing Services segment is involved in the creation, design, and implementation of interactive digital communications programs to the healthcare community through the Internet, multimedia, tablet PCs, mobile devices, and dimensional direct mails, as well as DIAGRAM, a proprietary software to deliver digital selling solutions through interactive communications exchanges that accommodate the schedules of healthcare providers. This segment is also engaged in the creation of teledetailing programs executed through tele-representatives. The Product Commercialization Services segment provides product commercialization solutions, including product distribution, product detailing, full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management to pharmaceutical, biotechnology, medical device, and diagnostics clients. PDI, Inc. has a strategic collaboration agreement with Transgenomic, Inc. The company was founded in 1987 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miao Graham GCFONov 25Buy1.6521,40035,31063,899Nov 25 12:47 PM
Miao Graham GCFONov 24Buy1.6560099042,499Nov 25 12:47 PM
Lurker NancyCEONov 10Buy1.6916,00027,090533,317Nov 12 09:25 AM
Lurker NancyCEONov 07Buy1.7733,00058,502517,317Nov 12 09:25 AM
Smith Jeffrey EdwardVP of Corporate DevelopmentNov 07Buy1.75200,000349,950467,194Nov 12 08:37 AM
TickerANF [NYSE]
CompanyAbercrombie & Fitch Co.
IndustryApparel Stores
Market Cap1.41BEPS (ttm)0.91
P/E22.27EPS this Y-75.80%
Forward P/E12.09EPS next Y6.62%
PEG1.40EPS past 5Y-27.50%
P/S0.36EPS next 5Y15.90%
P/B1.03EPS Q/Q225.00%
Dividend3.95%Sales Q/Q-11.80%
Insider Own2.14%Inst Own-
Insider Trans0.00%Inst Trans-1.24%
Short Float28.97%EarningsMar 04/b
Analyst Recom2.80Target Price29.50
Avg Volume2.42M52W Range23.12 - 44.99
Mar-04-15Downgrade Topeka Capital Markets Hold → Sell $26 → $18
Mar-04-15Reiterated Mizuho Neutral $27 → $23
Mar-04-15 04:31PMUpdates, advisories and surprises at MarketWatch
Mar-04-15 04:30PMUS STOCKS-Wall Street end down for 2nd day after rally; healthcare gains Reuters
Mar-04-15 04:28PMWhy American Eagle has outperformed Abercrombie at MarketWatch
Mar-04-15 04:18PMAbercrombie Is Selling Its Company Jet Bloomberg
Mar-04-15 04:04PMThe 52-Week Low Club for Wednesday at 24/7 Wall St.
Mar-04-15 03:02PMAbercrombie & Fitch: The Fall of an Empire at
Mar-04-15 02:10PMAmerican Eagle on top as A & F struggles at Financial Times
Mar-04-15 02:08PMAmerican Eagle Shows Strength Among Teens at The Wall Street Journal
Mar-04-15 02:06PMAbercrombie & Fitch turns to price cuts, outlets to escape its own hot mess at Fortune
Mar-04-15 01:28PMWednesday's Mid-Day Movers: PhotoMedex, Career Education And More Benzinga
Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer of casual apparel for men, women, and kids. It operates through three segments: U.S. Stores, International Stores, and Direct-to-Consumer. The company sells various products, including casual sportswear apparel comprising knit and woven shirts, graphic T-shirts, fleece, jeans and woven pants, shorts, sweaters, and outerwear; personal care products; and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, and Hollister brand names. It also offers bras, underwear, personal care products, sleepwear, and at-home products for girls under the Gilly Hicks brand. The company operates through 842 stores in the United States; and 157 stores in Canada, Europe, Asia, and Australia. Abercrombie & Fitch Co. sells its products through its stores and direct-to-consumer sales. The company was founded in 1892 and is headquartered in New Albany, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bostrom Robert E.SVP, Gen Cnsl & SecyJan 06Option Exercise0.001,20001,200Jan 08 04:10 PM
CHANG DIANEEVP of SourcingJun 23Sale43.032,00086,06124,114Jun 25 05:06 PM
GRIFFIN ARCHIE MDirectorJun 20Option Exercise0.001,500011,452Jun 23 06:00 PM
BACHMANN JAMES BDirectorJun 20Option Exercise0.003,000021,845Jun 23 06:00 PM
CHANG DIANEEVP of SourcingJun 02Sale38.517,195277,07926,114Jun 03 05:32 PM
CompanyMannatech, Incorporated
IndustryPersonal Products
Market Cap50.12MEPS (ttm)2.68
P/E7.00EPS this Y326.90%
Forward P/E-EPS next Y-
PEG0.40EPS past 5Y17.60%
P/S0.26EPS next 5Y17.50%
P/B1.72EPS Q/Q730.00%
Dividend-Sales Q/Q25.20%
Insider Own18.20%Inst Own16.40%
Insider Trans1.69%Inst Trans19.68%
Short Float2.15%EarningsMar 04/b
Analyst Recom-Target Price20.00
Avg Volume20.58K52W Range11.51 - 31.97
Mar-04-15 04:15PMMANNATECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Mar-04-15 07:00AMMannatech Reports Fourth Quarter and Year End Results Business Wire
Feb-27-15 09:27AMMANNATECH INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Feb-17-15 06:00AMMannatechs 2014 Donation Equal to 20 Million Servings of PhytoBlend Powder to Help Fight Global Childhood Malnutrition Business Wire
Feb-11-15 06:00AMMannatech Announces 100th Patent Business Wire
Feb-02-15 06:00AMMannatech Receives 99th Patent Business Wire
Dec-15-14 01:00PMMannatech Announces Official Launch in Spain Business Wire
Nov-28-14 09:42AMMannatech (MTEX) Upgraded From Hold to Buy at TheStreet
Nov-18-14 09:00AMMannatech Hosts Leadership Experience Event in Frisco, Texas Business Wire
Nov-14-14 01:04PMMANNATECH INC Financials EDGAR Online Financials
Mannatech, Incorporated develops and sells nutritional supplements, topical and skin care products, and weight-management products. It offers health products, including daily nutritional supplements, health solutions for children, and additional nutrients for specific body systems; and weight and fitness products to curb appetite and burn fat, build lean muscle tissue, and support recovery from overexertion. The company sells its products through independent sales associates and members in the United States, Canada, and Mexico; Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Sweden, the United Kingdom, and Ukraine; and Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, and Hong Kong. Mannatech, Incorporated was founded in 1993 and is headquartered in Coppell, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BALA ALFREDOPresidentNov 11Option Exercise6.241,83311,4331,833Nov 12 07:08 PM
Bikman Joel R.CMOSep 19Buy16.171,90030,7241,900Sep 22 04:04 PM
JOBE LARRY ADirectorSep 04Buy13.326,17482,21341,173Sep 04 06:51 PM
TOTH ROBERTDirectorAug 25Buy12.546,00075,21046,000Aug 26 08:29 AM
SINNOTT ROBERT ACEO & CSOAug 19Buy12.408009,9186,370Aug 19 07:34 PM
1 2 3 4 5 6 7 8 next